Minerva Neurosciences Reports Second Quarter 2021 Financial Results and Business Updates
02 août 2021 07h30 HE
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
Minerva Neurosciences to Report Second Quarter 2021 Financial Results and Business Updates on August 2, 2021
26 juil. 2021 08h30 HE
|
Minerva Neurosciences, Inc
WALTHAM, Mass., July 26, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...